查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014683

胃肠内视镜设备市场：按产品类型、可重复使用性、年龄层、应用和最终用户划分－2026-2032年全球市场预测

Gastrointestinal Endoscopy Devices Market by Product Type, Reusability, Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年，胃肠内视镜设备市值为160.7亿美元，预计2026年将成长至169.7亿美元，复合年增长率为5.96%，到2032年将达到241亿美元。

主要市场统计数据
基准年 2025 160.7亿美元
预计年份：2026年 169.7亿美元
预测年份 2032 241亿美元
复合年增长率 (%) 5.96%

全面概述了正在重新定义胃肠内视镜设备优先事项的临床需求、技术融合和采购趋势。

胃肠内视镜设备市场正处于临床需求与快速技术进步的交汇点，创新重点在于提高诊断准确性、治疗能力和病人安全性。依赖内视镜可视化的各项操作贯穿从常规筛检到复杂介入治疗的广泛临床路径。因此，参与临床实践、生产製造和医疗系统采购的相关人员都在优先考虑那些能够缩短手术时间、降低併发症率并与数位化医疗工作流程无缝整合的设备。

对成像技术的突破、感染控制的优先性以及治疗方法的扩展如何重塑竞争动态和产品蓝图。

近年来，在临床需求与技术能力融合的驱动下，胃肠内视镜生态系统中竞争优势的重新定义正经历变革性的加速。光学技术和高解析度成像技术的创新提升了诊断性能，而数位平台和人工智慧的融合则进一步增强了病灶检出、手术记录和术后分析。这些技术进步正在改变人们的预期，要求仪器製造商从产品设计的早期阶段就考虑软体整合、流程升级和互通性。

对美国 2025 年的新关税措施将如何影响内视镜设备产业相关人员的采购、购买行为和供应链韧性进行策略分析。

美国2025年实施的新关税措施对内视镜设备製造商和采购商产生了重大影响，波及采购、供应链设计和定价策略。由于关税导致进口零件和成品成本增加，製造商正在重新评估其全球采购体系，审查供应商合同，并探索近岸外包方案以减轻进口关税的影响。这些调整需要仔细评估总到岸成本、前置作业时间波动和供应商可靠性，尤其对于先进光学元件、照明系统和精密手术器械等特殊零件而言更是如此。

从详细的细分观点揭示产品类型、可重复使用性、患者人口统计特征、应用和医疗保健环境如何指导差异化的策略选择。

细分市场层面的趋势揭示了各细分市场特有的机会和限制因素，这些对于产品策略、商业化和临床应用都至关重要。按产品类型划分，市场涵盖配件、内视镜、手术器械和视觉化设备。配件进一步细分为摄影机、导管导引线和插入管；内视镜细分为软式内视镜内视镜和硬式内视镜；手术器械细分为镊子、剪刀和勒除器；可视化设备细分为摄影机、光源、显示器和视讯处理器。这种产品类型的细分突显了模组化和可升级性如何影响购买偏好：医院倾向于选择视觉化系统，而专科诊所则倾向于选择支援特定手术的最佳化配件组合。

跨区域分析揭示了临床需求模式、监管多样性和市场基础设施​​如何塑造世界各地不同的采用路径。

区域环境塑造了临床需求、监管路径和经营模式，进而影响短期部署模式和长期策略投资。在美洲，医疗服务体系呈现出大规模学术医疗中心、大规模的综合医疗网络以及数量快速增长的门诊机构并存的模式。这些因素共同催生了对扩充性平台的需求，这些平台需互通性，并提供强有力的临床证据以支持报销。报销框架和基于价值的采购倡议正日益影响采购流程，促使供应商提供可靠的卫生经济学数据和服务模式，以降低总手术成本。

对公司层面的优势进行权威评估，揭示技术广度、临床证据和全面的服务生态系统如何决定市场领导地位。

市场领导地位的形成源自于技术深度、与临床机构的紧密合作以及全面的服务传递。领先的医疗设备製造商正投资于涵盖光学系统、配件生态系统和整合式视觉化平台的端到端解决方案，以期在所有医疗环境中提供一致的治疗体验。医疗设备製造商与耗材供应商之间的策略合作，透过提供捆绑式服务包，降低了平台转换的门槛，简化了预算和维护流程，从而创造了具有竞争力的价值提案。

一系列切实可行且影响深远的建议，旨在指导领导者协调产品架构、供应链弹性和临床证据，从而建立可持续的竞争优势。

产业领导者必须果断且灵活地将新兴趋势转化为可持续的竞争优势。首先，他们必须投资于产品模组化和互通性，透过软体升级和配件更新而非彻底更换硬体来发展其平台，从而保持客户忠诚度并降低产品采用门槛。同时，他们必须扩展临床证据项目，不仅要证明治疗的有效性，还要证明其对后续医疗保健的益处。这些数据有助于巩固他们在以价值主导的采购模式中的地位，并为有利的报销谈判提供支持。

本研究清楚地展示了一种混合方法的研究途径，该方法结合了对临床医生的访谈、文献整合和检验，并检验了技术和商业性见解。

本调查方法结合了第一手和第二手研究手段，以确保分析的严谨性和实际应用价值。第一手研究包括对临床医生、采购经理、临床工程师和医疗设备製造商的高阶主管进行结构化访谈，以揭示实际应用中的推广驱动因素、营运挑战和采购惯例。除了这些直接洞察之外，还与监管和报销专家进行了有针对性的咨询，以了解不同司法管辖区的市场准入壁垒和驱动因素。

一项权威的综合分析揭示了为什么临床证据、强大的营运系统和有针对性的商业化相结合是胃肠内视镜设备成功的关键。

总而言之，胃肠内视镜设备的格局正在多种因素的共同作用下不断演变，包括成像技术的进步、感染控制的需求以及内视镜治疗作用的日益增强。这些因素正在重塑产品设计重点、经营模式和临床工作流程的结构。那些将平台策略与互通性、实证医学和卓越服务相结合的製造商，将更有能力满足医院、门诊中心和专科诊所不断变化的需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：胃肠内视镜设备市场：依产品类型划分

  • 配件
    • 相机
    • 导管导引线
    • 插入管
  • 内视镜
    • 软式内视镜
    • 硬式内视镜
  • 手术器械
    • 钳子
    • 剪刀
    • 勒除器
  • 影像显示设备
    • 相机
    • 光源
    • 监视器
    • 影像处理设备

第九章：胃肠内视镜设备市场的可重复使用性与性别差异

  • 可重复使用的内视镜
  • 免洗内视镜

第十章：胃肠内视镜设备市场：依年龄组别划分

  • 成人
  • 老年人
  • 儿童

第十一章：胃肠内视镜设备市场：依应用领域划分

  • 诊断
  • 治疗

第十二章：胃肠内视镜设备市场：依最终用户划分

  • 日间手术中心
  • 医院
  • 专科诊所

第十三章：胃肠内视镜设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：胃肠内视镜设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：胃肠内视镜设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国胃肠内视镜设备市场

第十七章：中国胃肠内视镜设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Ambu A/S
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • ConMed Corporation
  • Cook Medical, Inc.
  • Erbe Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • MICRO-TECH（Nanjing）Co., Ltd.
  • Olympus Corporation
  • PENTAX Medical America, Inc.
  • Richard Wolf GmbH
  • SB-KAWASUMI LABORATORIES, INC.
  • Smart Medical Systems Ltd.
  • Smith & Nephew plc
  • STERIS plc
  • Stryker Corporation
  • Teleflex Incorporated
Product Code: MRR-437E9896A4FC

The Gastrointestinal Endoscopy Devices Market was valued at USD 16.07 billion in 2025 and is projected to grow to USD 16.97 billion in 2026, with a CAGR of 5.96%, reaching USD 24.10 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 16.07 billion
Estimated Year [2026] USD 16.97 billion
Forecast Year [2032] USD 24.10 billion
CAGR (%) 5.96%

A comprehensive introduction describing clinical imperatives, technology convergence, and procurement dynamics that are redefining gastrointestinal endoscopy device priorities

The gastrointestinal endoscopy device landscape sits at the intersection of clinical necessity and rapid technological advancement, with innovation focused on improving diagnostic accuracy, therapeutic capability, and patient safety. Procedures that rely on endoscopic visualization underpin a wide range of clinical pathways, from routine screening to complex interventional therapies. Consequently, stakeholders across clinical practice, manufacturing, and health-system procurement prioritize devices that reduce procedure time, lower complication rates, and integrate seamlessly with digital healthcare workflows.

Contemporary device development emphasizes miniaturization, enhanced optics, ergonomic design, and connectivity to support image-guided interventions and remote consultation. Simultaneously, regulatory and reimbursement environments are evolving to reflect outcomes-based care and cost-containment pressures, prompting manufacturers to demonstrate value through clinical evidence and workflow efficiency. As a result, investment in research and development converges with an increased appetite among clinicians for platforms that enable both diagnostics and therapeutics under a unified technology stack.

As you consider strategic positioning, it is vital to understand how clinical trends, procurement behavior, and technology adoption interrelate. Hospitals and specialty clinics increasingly evaluate device portfolios not only on per-procedure performance but on lifecycle costs, reprocessing burdens, and compatibility with broader enterprise imaging systems. This dynamic presents opportunities for differentiated product design, value-driven service offerings, and partnerships that address the full continuum of care from outpatient screening to inpatient interventions.

An incisive analysis of how imaging leaps, infection-control priorities, and therapeutic expansion are reshaping competitive dynamics and product roadmaps

Over recent years, transformative shifts have accelerated the redefinition of competitive advantage within the gastrointestinal endoscopy ecosystem, driven by converging clinical needs and technological capability. Optical innovations and higher-resolution imaging have elevated diagnostic performance, while the integration of digital platforms and artificial intelligence is enhancing lesion detection, procedural documentation, and post-procedural analytics. These technological advances are shifting expectations, requiring device manufacturers to embed software, upgrade pathways, and interoperability considerations early in product design.

Simultaneously, the industry is responding to heightened concerns around infection control and device reprocessing. Single-use platforms have gained attention as a pragmatic option to reduce cross-contamination risk and alleviate the operational burden of complex reprocessing workflows. This has triggered a re-evaluation of capital allocation versus consumable-based models among health systems, with some providers preferring to trade equipment ownership for reliable disposables that simplify logistics and regulatory compliance.

Another significant shift is the broadening role of endoscopy beyond diagnostics toward minimally invasive therapeutics. Devices that facilitate endoluminal therapies, including advanced hemostasis, tissue resection, and endoscopic suturing, are enabling clinicians to manage conditions that previously required surgery. This transition is spurring demand for multi-functional platforms and accessory instruments that support a spectrum of interventional procedures, which in turn is reshaping training requirements, procedural guidelines, and reimbursement conversations. Collectively, these shifts are redefining product roadmaps and competitive strategies across the value chain.

A strategic examination of how new United States tariff measures in 2025 are influencing sourcing, procurement behavior, and supply chain resilience for endoscopy device stakeholders

The implementation of new tariff measures in the United States during 2025 has introduced material implications for procurement, supply chain design, and pricing strategies for endoscopy device manufacturers and buyers. Tariff-driven cost inflations on imported components and finished goods are prompting manufacturers to reassess global sourcing footprints, revisit supplier agreements, and explore nearshoring options to mitigate exposure to import duties. These adjustments require a careful evaluation of total landed cost, lead-time variability, and supplier reliability, especially for specialized components such as advanced optics, illumination systems, and precision surgical instruments.

Health systems and purchasing consortia are reacting by tightening contracting cycles and amplifying emphasis on total cost of ownership rather than unit price alone. Facility-level decision-makers are scrutinizing procurement contracts to identify opportunities for volume-based discounts, long-term service agreements, and bundled offerings that can offset incremental tariff-related costs. At the product development level, manufacturers face choices between localizing assembly, redesigning products to incorporate alternative components, or absorbing higher input costs, each with implications for margins and time-to-market.

From a strategic standpoint, businesses that proactively communicate transparent pricing adjustments and collaborate with customers on phased implementation plans tend to preserve market access more effectively. Additionally, organizations that invest in supply chain resilience-through diversified supplier networks, strategic inventory buffers, and agile manufacturing arrangements-are better positioned to stabilize delivery and maintain customer confidence amid tariff-related disruptions. Regulatory compliance and documentation become more central as customs classifications and duty treatments influence landed cost, underscoring the need for coordinated commercial, legal, and operational responses.

A nuanced segmentation perspective illuminating how product type, reusability, patient demographics, application, and care setting drive differentiated strategic choices

Segment-level dynamics reveal differentiated opportunities and constraints that inform product strategy, commercialization, and clinical adoption. Based on Product Type the market covers Accessories, Endoscopes, Operative Devices, and Visualization Equipment, with Accessories further studied across Cameras, Guide Wires, and Insertion Tubes, Endoscopes further divided into Flexible Endoscopes and Rigid Endoscopes, Operative Devices examined through Forceps, Scissors, and Snares, and Visualization Equipment broken down into Cameras, Light Sources, Monitors, and Video Processors. This product-type granularity highlights how modularity and upgradeability shape purchasing preferences, with hospitals often favoring integrated visualization systems and specialty clinics opting for optimized accessory bundles that support targeted procedures.

Based on Reusability the market differentiates between Reusable Endoscopes and Single-use Endoscopes, a segmentation that directly relates to institutional priorities around infection control, reprocessing capacity, and lifecycle economics. Based on Age Group devices and procedural pathways are considered across Adults, Geriatrics, and Pediatrics, prompting tailored design considerations such as channel size, scope flexibility, and anesthesia requirements to accommodate patient cohorts with distinct anatomical and clinical risk profiles. Based on Application the division between Diagnostics and Therapeutics signals divergent value propositions: diagnostic platforms prioritize imaging fidelity and lesion detection adjuncts, while therapeutic devices emphasize instrument channel compatibility, accessory integration, and force transmission for interventional tasks.

Based on End User the market is studied across Ambulatory Surgery Centers, Hospitals, and Specialty Clinics, each setting presenting unique procurement models, capital constraints, and throughput expectations. Ambulatory centers often prioritize rapid turnover and compact footprint solutions that optimize procedural volume, whereas hospitals require devices that support a broader case mix and cross-departmental interoperability. Specialty clinics focus on niche procedural excellence, adopting devices that deliver high-performance outcomes for focused indications. Understanding how these segments interact and where adoption curves accelerate provides the basis for tailored go-to-market strategies and product roadmaps.

A cross-regional analysis revealing how clinical demand patterns, regulatory diversity, and market infrastructure shape differentiated adoption pathways across global territories

Regional conditions govern clinical demand, regulatory pathways, and commercial models, shaping both near-term adoption patterns and longer-term strategic investments. In the Americas, healthcare delivery is characterized by a mix of high-volume academic centers, large integrated delivery networks, and proliferating outpatient facilities, which together create demand for scalable platforms that offer interoperability and strong clinical evidence to support reimbursement. Reimbursement frameworks and value-based purchasing initiatives increasingly influence procurement cycles, motivating vendors to present robust health economic data and service models that reduce total procedural cost.

In Europe, Middle East & Africa regulatory harmonization in some jurisdictions coexists with varied reimbursement regimes and infrastructure maturity across countries, requiring tailored market-entry plans. Manufacturers often prioritize regulatory approvals and local clinical partnerships to accelerate adoption, while flexible financing and training programs can overcome capacity constraints in emerging markets. The Asia-Pacific region demonstrates fast-paced adoption in urban tertiary centers paired with distinct procurement behaviors driven by public health priorities, local manufacturing ecosystems, and an expanding network of private specialty clinics. Growth in procedure volumes, investments in digital health, and rising emphasis on minimally invasive care are notable drivers.

Across regions, successful commercial strategies combine global platform consistency with localized value propositions, including language-specific software interfaces, tailored training curricula, and reimbursement support. Vendors that invest in regional clinical evidence generation and build robust service networks tend to sustain adoption momentum by addressing the specific operational and regulatory pain points that vary from one geography to another.

A decisive appraisal of company-level strengths showing why technological breadth, clinical evidence, and comprehensive service ecosystems determine market leadership

Market leadership reflects a combination of technological depth, clinical engagement, and comprehensive service offerings. Leading device-makers invest in end-to-end solutions that span optics, accessory ecosystems, and integrated visualization platforms to deliver consistent procedural experiences across care settings. Strategic partnerships between capital equipment manufacturers and consumables suppliers create defensible value propositions by lowering barriers to platform switching and offering bundled service packages that simplify budgeting and maintenance.

Companies that prioritize clinical evidence generation through multicenter studies and investigator-led research are better positioned to influence guideline development and secure favorable formulary placement within hospital systems. Equally, those that invest in scalable training and education programs build clinician familiarity and procedural confidence, accelerating adoption of advanced therapeutic features. From an operational perspective, strong aftermarket service capabilities-including rapid parts replacement, remote diagnostics, and preventive maintenance-are decisive factors in long-term customer retention.

Emerging entrants are differentiating on specific dimensions such as single-use technologies, AI-enabled diagnostic support, and purpose-built devices for niche procedures. These focused strategies can yield rapid uptake in targeted segments, particularly when supported by compelling clinical outcomes and streamlined procurement packages. For established players, sustaining competitive advantage requires continuous platform evolution, investment in interoperable software ecosystems, and proactive engagement with payer and provider stakeholders to align product value with evolving care pathways.

A set of pragmatic, high-impact recommendations guiding leaders to align product architecture, supply resilience, and clinical evidence for sustained competitive advantage

Industry leaders must act with clarity and agility to translate emerging trends into durable competitive advantage. First, invest in product modularity and interoperability so platforms can evolve through software upgrades and accessory refreshes rather than complete hardware replacement, preserving customer loyalty and lowering adoption friction. Concurrently, expand clinical evidence programs that demonstrate not only procedural efficacy but also downstream health-economic benefits; such data helps to secure placement in value-driven purchasing models and supports favorable reimbursement conversations.

Second, strengthen supply chain resilience through diversification, strategic regional partnerships, and nearshoring options for critical components. This reduces exposure to tariff shocks, logistics disruptions, and component scarcity while enabling faster response to localized demand spikes. Third, develop differentiated service models that integrate preventative maintenance, digital monitoring, and tiered support contracts to create recurring revenue streams and deepen customer relationships. Attention to training and clinician adoption is also essential; comprehensive curricula and proctoring programs accelerate safe uptake of therapeutic capabilities and broaden the addressable market for complex procedures.

Finally, pursue targeted commercial strategies by aligning offerings with the specific needs of ambulatory surgery centers, hospitals, and specialty clinics. For ambulatory centers emphasize compact, cost-effective workflows; for hospitals prioritize cross-departmental interoperability and robustness; and for specialty clinics highlight performance attributes tailored to niche indications. By aligning R&D, commercialization, and supply chain strategies to these priorities, organizations can capture sustainable growth while mitigating operational risk.

A clear exposition of the mixed-method research approach combining clinician interviews, literature synthesis, and triangulation to validate technological and commercial insights

The research methodology blends primary and secondary approaches to ensure analytical rigor and practical relevance. Primary research drew on structured interviews with clinicians, procurement leaders, clinical engineers, and senior executives across device manufacturers, conducted to surface real-world adoption drivers, operational pain points, and procurement practices. These firsthand insights were supplemented by targeted consultations with regulatory and reimbursement experts to contextualize market access barriers and facilitators across different jurisdictions.

Secondary research included systematic reviews of peer-reviewed clinical literature, professional society guidelines, patent filings, and publicly available regulatory documentation to ground technological and clinical assertions in established evidence. Trade publications, conference proceedings, and company disclosures were analyzed to capture product launches, strategic partnerships, and modality-specific innovations. Data triangulation procedures compared findings across sources to validate trends and resolve discrepancies.

Analytical techniques included thematic coding of qualitative interviews, comparative assessment of device feature sets, and scenario analysis to evaluate supply chain and regulatory contingencies. Quality assurance engaged independent subject-matter reviewers to assess methodological soundness and factual accuracy. Where uncertainties remain, the methodology explicitly documents assumptions and recommends areas for future primary study to close evidence gaps.

A conclusive synthesis highlighting why integration of clinical evidence, resilient operations, and targeted commercialization will define success in gastrointestinal endoscopy devices

In summary, the gastrointestinal endoscopy device environment is evolving under the combined influence of imaging advances, infection-control imperatives, and the expanding role of endoscopic therapeutics. These forces are reshaping product design priorities, commercial models, and the structure of clinical workflows. Manufacturers that align platform strategies with interoperability, evidence generation, and service excellence will be best positioned to meet the changing demands of hospitals, ambulatory centers, and specialty clinics.

Supply chain robustness and strategic responses to tariff developments are immediate operational priorities, while long-term competitiveness hinges on modular architectures and software-enabled value propositions. Segmentation insights underscore the need for differentiated offerings across product types, reusability profiles, patient age groups, applications, and end-user settings. Regional nuances reinforce the value of localized strategies that reflect regulatory processes, reimbursement mechanisms, and infrastructure maturity.

Overall, organizations that integrate clinical insight, operational resilience, and targeted commercialization will be well placed to convert technological opportunity into sustainable market performance, while delivering improved patient outcomes and procedural efficiencies across the continuum of gastrointestinal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Endoscopy Devices Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Cameras
    • 8.1.2. Guide Wires
    • 8.1.3. Insertion Tubes
  • 8.2. Endoscopes
    • 8.2.1. Flexible Endoscopes
    • 8.2.2. Rigid Endoscopes
  • 8.3. Operative Devices
    • 8.3.1. Forceps
    • 8.3.2. Scissors
    • 8.3.3. Snares
  • 8.4. Visualization Equipment
    • 8.4.1. Cameras
    • 8.4.2. Light Sources
    • 8.4.3. Monitors
    • 8.4.4. Video Processors

9. Gastrointestinal Endoscopy Devices Market, by Reusability

  • 9.1. Reusable Endoscopes
  • 9.2. Single-use Endoscopes

10. Gastrointestinal Endoscopy Devices Market, by Age Group

  • 10.1. Adults
  • 10.2. Geriatrics
  • 10.3. Pediatrics

11. Gastrointestinal Endoscopy Devices Market, by Application

  • 11.1. Diagnostics
  • 11.2. Therapeutics

12. Gastrointestinal Endoscopy Devices Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Gastrointestinal Endoscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastrointestinal Endoscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastrointestinal Endoscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Gastrointestinal Endoscopy Devices Market

17. China Gastrointestinal Endoscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Ambu A/S
  • 18.7. Becton, Dickinson and Company
  • 18.8. Boston Scientific Corporation
  • 18.9. Cardinal Health
  • 18.10. ConMed Corporation
  • 18.11. Cook Medical, Inc.
  • 18.12. Erbe Elektromedizin GmbH
  • 18.13. Fujifilm Holdings Corporation
  • 18.14. Johnson & Johnson
  • 18.15. KARL STORZ SE & Co. KG
  • 18.16. Medtronic plc
  • 18.17. MICRO-TECH (Nanjing) Co., Ltd.
  • 18.18. Olympus Corporation
  • 18.19. PENTAX Medical America, Inc.
  • 18.20. Richard Wolf GmbH
  • 18.21. SB-KAWASUMI LABORATORIES, INC.
  • 18.22. Smart Medical Systems Ltd.
  • 18.23. Smith & Nephew plc
  • 18.24. STERIS plc
  • 18.25. Stryker Corporation
  • 18.26. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 184. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 185. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 214. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 215. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 224. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 225. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 227. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)